Blog2025-03-18T10:11:14+00:00

AssurX Blog

Straight talk for regulated industries.

305, 2017

Cloud Computing Impact in the Energy and Utilities Sector

May 3rd, 2017|Archives, Energy & Utilities Industry, NERC Compliance, Regulatory Compliance Management|

Technology-averse energy & utilities companies are about to embrace the power of cloud computing technology, say many leading experts. Cloud Computing Technology = Enhanced Perform [...]

1704, 2017

Prioritize QMS Process Automation or Risk Failure

April 17th, 2017|Archives, eMDR, FDA Regulated Industries, Food & Beverage Industry, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management|

A common pitfall in QMS process automation occurs with a poorly planned process automation strategy.  Too often, the temptation is to automate all quality processes at once and streaml [...]

1104, 2017

Successful QMS Implementation Requires Clearly Defined Processes

April 11th, 2017|Archives, eMDR, FDA Regulated Industries, Food & Beverage Industry, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management|

Industry-leading quality management systems (QMS) are built with clearly defined processes and workflows developed by the implementation team. While initially it may seem overwhelming, [...]

1004, 2017

China Addresses Life Sciences Regulatory Compliance Concerns

April 10th, 2017|Archives, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management, Risk Management|

China has often faced criticism for lax regulation of drug and medical device manufacturing. In addition, long-term accusations of bribery for inspection favoritism is still a real con [...]

304, 2017

FDA Warning Letters Emphasize Document Control System Compliance

April 3rd, 2017|Archives, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management, Risk Management|

First-quarter 2017 Food and Drug Administration (FDA) warning letters emphasize a lack of effective document control system compliance. Two recent warning letters are patent examples.  [...]

2803, 2017

FDA States Clear cGMP Expectations for Combination Products

March 28th, 2017|Archives, FDA Regulated Industries, Medical Device Industry, Pharmaceutical Industry, Quality Management, Regulatory Compliance Management, Risk Management|

The Food and Drug Administration (FDA) recently released a final guidance on Current Good Manufacturing Practice (cGMP) Requirements for Combination Products. This guidance provides cl [...]

Go to Top